Sunday, January 25, 2009

FDA Clears Geron to Begin Clinical Testing

FDA Clears Geron to Begin Clinical Testing of hESC Product Genetic Engineering News (press release) - New Rochelle,NY,USA The FDA is allowing Geron to initiate a Phase I trial using its human embryonic stem cell (hESC) product, GRNOPC1, in patients with acute spinal cord injury ...
http://www.genengnews.com/news/bnitem.aspx?name=48516904


Arizona Internet Marketing
Arizona Biotechnology Marketing
Biotechnology News

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home